Skip to main content
Clinical Trials/NCT03614130
NCT03614130CompletedNot Applicable

Clinical Performance of a Silicone Hydrogel Following Six Nights of Extended Wear

Alcon Research3 sites in 1 country22 target enrollmentStarted: August 23, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
22
Locations
3
Primary Endpoint
Visual Acuity (VA) With Study Lenses, Collected by Eye

Study Overview

Brief Summary

The purpose of this clinical study is to evaluate the on-eye performance of an investigational soft contact lens compared to a commercially available soft contact lens following 1 week of extended wear.

Detailed Description

Subjects will be randomized to wear the investigational contact lens in 1 eye and the commercially available contact lens in the other eye. Subjects will be expected to attend 3 scheduled study visits: Day 1 Baseline/Dispense; Day 2 Follow-up; and Week 1 Follow-up/Exit. The expected duration of exposure to each of the study lenses for all randomized, completed subjects was approximately 7 days / 6 nights of wear.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Able to understand and sign an Institutional Review Board/Ethics Committee-approved Informed Consent form.
  • Successful wear of spherical soft contact lenses in both eyes during the past 3 months for a minimum of 5 days per week and in an extended wear modality a minimum of 1 night per week.
  • Best Corrected Visual Acuity (BCVA) of 20/25 or better in each eye.
  • Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

  • Any condition, use of medications, or surgery that could contraindicate contact lens wear, as determined by the Investigator.
  • Current Biofinity© lens wearer.
  • Pregnant or breast-feeding.
  • Other protocol-specified exclusion criteria may apply.

Outcomes

Primary Outcomes

Visual Acuity (VA) With Study Lenses, Collected by Eye

Time Frame: Day 1 Dispense; Day 2 Follow-up (ideally within 4 hours of awakening); Week 1 Follow-up/Exit

Visual acuity (VA) was assessed for each eye individually with study lenses in place using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials